| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.RCL.2012.06.003 |
| P698 | PubMed publication ID | 22974781 |
| P50 | author | Gregory P. Kalemkerian | Q124968136 |
| Shirish M Gadgeel | Q124968314 | ||
| P2093 | author name string | Suresh S Ramalingam | |
| P433 | issue | 5 | |
| P304 | page(s) | 961-974 | |
| P577 | publication date | 2012-09-01 | |
| P1433 | published in | Radiologic Clinics of North America | Q15755454 |
| P1476 | title | Treatment of lung cancer | |
| P478 | volume | 50 |
| Q37226062 | 125I Brachytherapy in Locally Advanced Nonsmall Cell Lung Cancer After Progression of Concurrent Radiochemotherapy |
| Q36948358 | A microfluidic system to study the cytotoxic effect of drugs: the combined effect of celecoxib and 5-fluorouracil on normal and cancer cells |
| Q35688617 | A new PET/CT volumetric prognostic index for non-small cell lung cancer |
| Q96348540 | Age-different extent of resection for clinical IA non-small cell lung cancer: analysis of nodal metastasis |
| Q59799450 | Anticancer activity of 2'-hydroxyflavanone towards lung cancer |
| Q38723069 | Apoptosis of Lewis Lung Carcinoma Cells Induced by Microwave via p53 and Proapoptotic Proteins In vivo |
| Q57169738 | Bioreducible Poly(Amino Ethers) Based mTOR siRNA Delivery for Lung Cancer |
| Q92890031 | CPSF3 is a promising prognostic biomarker and predicts recurrence of non-small cell lung cancer |
| Q36183170 | Clinical value of microRNA-23a upregulation in non-small cell lung cancer |
| Q37109499 | Concordance of folate receptor-α expression between biopsy, primary tumor and metastasis in breast cancer and lung cancer patients |
| Q89422561 | Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance |
| Q38335478 | Desmoglein 3: a help or a hindrance in cancer progression? |
| Q52886289 | Evaluation of role of Notch3 signaling pathway in human lung cancer cells. |
| Q37589223 | Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab. |
| Q47153479 | Increased Jab1/COPS5 is associated with therapeutic response and adverse outcome in lung cancer and breast cancer patients |
| Q50659097 | Induction chemotherapy for T3N0M0 non-small-cell lung cancer increases the rate of complete resection but does not confer improved survival. |
| Q36268729 | Knockdown of POLA2 increases gemcitabine resistance in lung cancer cells |
| Q47916877 | Lung cancer guidelines in Sweden, Denmark, Norway and Finland: a comparison. |
| Q41180293 | MiR-146b-5p functions as a suppressor miRNA and prognosis predictor in non-small cell lung cancer |
| Q90293553 | Preoperative D-dimer level is an independent prognostic factor for non-small cell lung cancer after surgical resection: a systematic review and meta-analysis |
| Q39011847 | Regulation of cell survival by the HIP-55 signaling network |
| Q38925887 | Risk-stratifying capacity of PET/CT metabolic tumor volume in stage IIIA non-small cell lung cancer |
| Q59797636 | Short- and long-term outcomes in elderly patients with locally advanced non-small-cell lung cancer treated using video-assisted thoracic surgery lobectomy |
| Q90465688 | Significance of the epidermal growth factor receptor mutation status and differences among molecular subgroups in surgically resected lung microinvasive adenocarcinoma |
| Q94503231 | Synergistic combinations of paclitaxel and withaferin A against human non-small cell lung cancer cells |
| Q35677914 | The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients |
| Q88993794 | The utilisation of convolutional neural networks in detecting pulmonary nodules: a review |
| Q47107773 | Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model. |
Search more.